J&J's McNeil Gets New Trial After $48M Motrin Reaction Loss
The Johnson & Johnson subsidiary that makes Motrin will get a retrial in a case in which a man was awarded $48 million after he developed a skin condition from taking...To view the full article, register now.
Already a subscriber? Click here to view full article